Skip to main content

Table 3 Univariate analyses of recurrence-free survival depending on treatment characteristics

From: A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control

 

N

Estimated 1-year RFS (95% CI)

Estimated 2-year RFS (95% CI)

Estimated 5-year RFS (95% CI)

P (log-rank)*

Margin status after initial resection

 R0

13

83.1 (47.2–95.5)

63.3 (28.6–84.6)

63.3 (28.6–84.6)

 

 R1/2

55

91.9 (79.8–96.9)

91.9 (79.8–96.9)

87.1 (73.3–94.0)

0.053

Re-excision

 No

13

82.1 (44.4–95.3)

59.8 (24.1–83.1)

47.9 (15.5–74.7)

 

 Yes

55

92.0 (80.1–96.9)

92.0 (80.1–96.9)

89.6 (76.7–95.6)

0.002

Margin status after first treatment round (initial resection + re-excision)

 R0

65

89.9 (78.8–95.3)

86.0 (73.9–92.8)

84.0 (71.3–91.4)

 

 R1

3

100 (−)

100 (−)

(−)

Wound closure during first treatment round

 Primary closure

35

80.8 (62.1–90.9)

73.6 (53.8–85.9)

69.7 (49.6–83.1)

 

 Non-primary closure (plastic surgical tissue transfer)

32

100 (−)

100 (−)

96.2 (75.7–99.4)

0.006

Adjuvant radiotherapy

 No

65

89.9 (78.8–95.3)

86.0 (73.9–92.8)

82.0 (69.0–89.9)

 

 Yes

3

100 (−)

100 (−)

100 (−)

Distance of closest negative margin (R0 group) in cm

 ≤0.2

11

81.8 (44.7–95.1)

71.6 (35.0–89.9)

71.6 (35.0–89.9)

 

 0.2–0.5

11

88.9 (43.3–98.4)

71.1 (23.3–92.3)

71.1 (23.3–92.3)

 

 0.5–1.0

10

77.8 (36.5–93.9)

77.8 (36.5–93.9)

77.8 (36.5–93.9)

 

 >1.0

16

100 (−)

100 (−)

100 (−)

0.039**

  1. RFS recurrence-free survival, CI confidence interval
  2. *Log-rank test for equality of survivor functions, **Global log-rank test for the trend of survivor functions